SARS-CoV-2 in Pregnancy—More Hints of Rare Complications
-
By
-
George L. Anesi
-
Arturo Casadevall
-
May 7, 2026
Clinical Scorecard: SARS-CoV-2 During Pregnancy—Emerging Evidence of Uncommon Complications
At a Glance
| Category | Detail |
|---|
| Condition | |
| Key Mechanisms | Potential teratogenic effects, systemic inflammation, and their roles in adverse outcomes. |
| Target Population | |
| Care Setting | |
Key Highlights
- Studies show variable evidence of increased congenital anomalies associated with maternal SARS-CoV-2 infection; specify significance.
Guideline-Based Recommendations
Diagnosis
Management
Monitoring & Follow-up
- Monitor for potential congenital anomalies in infants born to mothers with SARS-CoV-2 infection.
- Monitor maternal health post-infection for complications.
Risks
Patient & Prescribing Data
Vaccination is crucial; consider additional treatments for severe cases.
Clinical Best Practices
- Encourage vaccination against COVID-19 in pregnant patients.
- Conduct thorough assessments of maternal health and potential complications, including specific tests for COVID-19 related issues.
- Stay updated on emerging evidence regarding SARS-CoV-2 and pregnancy.
Related Resources & Content
